Live feed08:30:00·12dNEWSReleasevia QuantisnowIGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline AnalysisByQuantisnow·Wall Street's wire, on your screen.IGC· IGC Pharma Inc.Health Care
